INTS
Price
$0.46
Change
+$0.01 (+2.22%)
Updated
Jun 6 closing price
Capitalization
8.25M
70 days until earnings call
MRKR
Price
$1.77
Change
+$0.25 (+16.45%)
Updated
Jun 6 closing price
Capitalization
16.28M
Interact to see
Advertisement

INTS vs MRKR

Header iconINTS vs MRKR Comparison
Open Charts INTS vs MRKRBanner chart's image
Intensity Therapeutics
Price$0.46
Change+$0.01 (+2.22%)
Volume$749.16K
Capitalization8.25M
Marker Therapeutics
Price$1.77
Change+$0.25 (+16.45%)
Volume$166.54K
Capitalization16.28M
INTS vs MRKR Comparison Chart
Loading...
INTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INTS vs. MRKR commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INTS is a Buy and MRKR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (INTS: $0.31 vs. MRKR: $1.10)
Brand notoriety: INTS and MRKR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INTS: 141% vs. MRKR: 105%
Market capitalization -- INTS: $8.25M vs. MRKR: $16.28M
INTS [@Biotechnology] is valued at $8.25M. MRKR’s [@Biotechnology] market capitalization is $16.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INTS’s FA Score shows that 0 FA rating(s) are green whileMRKR’s FA Score has 1 green FA rating(s).

  • INTS’s FA Score: 0 green, 5 red.
  • MRKR’s FA Score: 1 green, 4 red.
According to our system of comparison, MRKR is a better buy in the long-term than INTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INTS’s TA Score shows that 4 TA indicator(s) are bullish while MRKR’s TA Score has 4 bullish TA indicator(s).

  • INTS’s TA Score: 4 bullish, 2 bearish.
  • MRKR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, INTS is a better buy in the short-term than MRKR.

Price Growth

INTS (@Biotechnology) experienced а -16.35% price change this week, while MRKR (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

INTS is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRKR($16.3M) has a higher market cap than INTS($8.25M). MRKR YTD gains are higher at: -64.630 vs. INTS (-82.176). MRKR has higher annual earnings (EBITDA): -10.19M vs. INTS (-16.27M). MRKR has more cash in the bank: 9M vs. INTS (2.59M). MRKR has less debt than INTS: MRKR (0) vs INTS (138K). INTS (0) and MRKR (0) have equivalent revenues.
INTSMRKRINTS / MRKR
Capitalization8.25M16.3M51%
EBITDA-16.27M-10.19M160%
Gain YTD-82.176-64.630127%
P/E RatioN/AN/A-
Revenue00-
Total Cash2.59M9M29%
Total Debt138K0-
FUNDAMENTALS RATINGS
MRKR: Fundamental Ratings
MRKR
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
3

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INTSMRKR
RSI
ODDS (%)
Bullish Trend 13 days ago
53%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
72%
Bullish Trend 12 days ago
81%
Momentum
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
MACD
ODDS (%)
Bullish Trend 12 days ago
53%
Bullish Trend 12 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 13 days ago
80%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 28 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
70%
Bearish Trend 13 days ago
84%
Aroon
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
INTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

INTS and

Correlation & Price change

A.I.dvisor tells us that INTS and GBIO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INTS and GBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTS
1D Price
Change %
INTS100%
-2.85%
GBIO - INTS
29%
Poorly correlated
-1.11%
MRKR - INTS
29%
Poorly correlated
-4.35%
ACAD - INTS
28%
Poorly correlated
-0.77%
GPCR - INTS
27%
Poorly correlated
-6.96%
CCCC - INTS
27%
Poorly correlated
-3.08%
More

MRKR and

Correlation & Price change

A.I.dvisor tells us that MRKR and CGON have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MRKR and CGON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRKR
1D Price
Change %
MRKR100%
-4.35%
CGON - MRKR
32%
Poorly correlated
-0.94%
RCKT - MRKR
31%
Poorly correlated
+6.44%
EYPT - MRKR
30%
Poorly correlated
+18.12%
PMVP - MRKR
30%
Poorly correlated
+0.01%
XNCR - MRKR
30%
Poorly correlated
-2.58%
More